VBWG
Slides

Core Curriculum

• Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section V: Multiple risk and CV disease prevention

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment. Volume VI. This edition of the core curriculum is special, because it marks the 10th anniversary of the Vascular Biology Working Group. It covers basic science and clinical advances in vascular biology in a spectrum of disorders. The material is presented in five sections:

This slide/lecture program discusses strategies to prevent cardiovascular disease through aggressive management of multiple risk factors. The focus is on treatment of hypertension and dyslipidemia. The contents provide an update in key areas.

  • Recent data showing an epidemic increase in the population at high risk for cardiovascular disease
  • New knowledge of basic mechanisms of vascular pathophysiology related to hypertension and dyslipidemia as well as obesity and the metabolic syndrome
  • An update on clinical trials that support intensive multifactorial treatment for the reduction of cardiovascular disease
  • Important information on statins and safety, including recent data from the FDA
  • Latest guidelines for managing hypertension and dyslipidemia as well as for multifactorial risk reduction in high-risk patients




04VBWGCoreMultipleRiskS01.ppt

Download 04VBWGCoreMultipleRiskS01.ppt (18 slides - 3.1MB)

Slide 1 Slide 2 Slide 3 Slide 4 Slide 5 Slide 6 Slide 7 Slide 8 Slide 9 Slide 10 Slide 11 ’ Slide 13 Slide 14 Slide 15 Slide 16 ’ Slide 18

04VBWGCoreMultipleRiskS02.ppt

Download 04VBWGCoreMultipleRiskS02.ppt (6 slides - 1.5MB)

Slide 1 VBWG VBWG Slide 4 Slide 5 Slide 6

04VBWGCoreMultipleRiskS03.ppt

Download 04VBWGCoreMultipleRiskS03.ppt (24 slides - 4.3MB)

Slide 1 Slide 2 Slide 3 Slide 4 Slide 5 Slide 6 Slide 7 Slide 8 Slide 9 Slide 10 Slide 11 ’ ’ Slide 14 Slide 15 Slide 16 Slide 17 Slide 18 Slide 19 Slide 20 Slide 21 Slide 22 ’ Slide 24

04VBWGCoreMultipleRiskS04.ppt

Download 04VBWGCoreMultipleRiskS04.ppt (2 slides - 0.4MB)

Slide 1 Slide 2

04VBWGCoreMultipleRiskS05.ppt

Download 04VBWGCoreMultipleRiskS05.ppt (8 slides - 1.2MB)

Slide 1 Slide 2 Slide 3 Slide 4 Slide 5 Slide 6 Slide 7 Slide 8

04VBWGCoreMultipleRiskS06.ppt

Download 04VBWGCoreMultipleRiskS06.ppt (19 slides - 3.0MB)

Slide 1 Slide 2 Slide 3 Slide 4 Slide 5 VBWG VBWG Slide 8 Slide 9 Slide 10 Slide 11 Slide 12 Slide 13 Slide 14 Slide 15 Slide 16 Slide 17 Slide 18 Slide 19
Published by Medical Education Consultants, LLC (MEDCON), on behalf of the University of Florida College of Medicine.

The editorial content of this program does not necessarily reflect the views or recommendations of the University of Florida College of Medicine or AstraZeneca, King Pharmaceuticals Inc, Pfizer Inc, and Wyeth Pharmaceuticals, or the publisher. The reader is advised to consult the full prescribing information of each product prior to use.

This program was prepared and produced by Medical Education Consultants, LLC, Westport, Connecticut, on behalf of the University of Florida College of Medicine through an unrestricted educational grant provided by AstraZeneca, King Pharmaceuticals Inc, Pfizer Inc, and Wyeth Pharmaceuticals.

©2004 Medical Education Consultants, LLC (MEDCON). All rights reserved.

biologycardiovascularCurriculumPreventionvascularVBWG

Related at vwbg.org

Core Curriculum

Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section IV - Update: RAAS manipulation and cardiovascular risk--Hope for Peace?

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment.

Core Curriculum

Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section IV: RAAS manipulation and cardiovascular risk

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment.

Core Curriculum

Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section III: Heart failure: The new vascular biology imperative to blunt progression

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment.
More related